Emend and renal failure Patient Reports February 11, 2012

Emend Side Effects Report #4850988-X
Emend side effect was reported by a Physician from FRANCE on Nov 29, 2005. Female patient, 69 years of age, was diagnosed with prophylaxis of nausea and vomiting, uterine cancer  and was treated with Emend. After drug was administered, patient experienced the following side effects: bone marrow failure, enterocolitis, gastrointestinal haemorrhage, haemodialysis, renal failure. Emend dosage: unknown. During the same period patient was treated with CISPLATIN, IFOSFAMIDE, DOXORUBICIN, FUROSEMIDE, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.

Emend Side Effects Report #4855865-6
Emend side effect was reported by a Physician from FRANCE on Nov 29, 2005. Female patient, 69 years of age, was diagnosed with prophylaxis of nausea and vomiting, uterine cancer  and was treated with Emend. After drug was administered, patient experienced the following side effects: bone marrow failure, enterocolitis, gastrointestinal haemorrhage, haemodialysis, renal failure. Emend dosage: unknown. During the same period patient was treated with CISPLATIN, IFOSFAMIDE, DOXORUBICIN, FUROSEMIDE, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.

Emend Side Effects Report #4871377-8
Emend side effect was reported by a Physician from FRANCE on Nov 29, 2005. Female patient, 69 years of age, was diagnosed with prophylaxis of nausea and vomiting, uterine cancer  and was treated with Emend. After drug was administered, patient experienced the following side effects: bone marrow failure, enterocolitis, gastrointestinal haemorrhage, haemodialysis, renal failure. Emend dosage: unknown. During the same period patient was treated with CISPLATIN, IFOSFAMIDE, DOXORUBICIN, FUROSEMIDE, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.

Emend Side Effects Report #5199462-4
Emend side effect was reported by a Physician from UNITED STATES on Dec 20, 2006. Female patient, 71 years of age, weighting 185.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Emend. After drug was administered, patient experienced the following side effects: angioneurotic oedema, diarrhoea, hypersensitivity, pyelonephritis, renal failure, urinary tract infection . Emend dosage: unknown. During the same period patient was treated with CAP VORINOSTAT UNK, DECITABINE. Patient was hospitalized. Patient recovered.